Cargando…
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465303/ https://www.ncbi.nlm.nih.gov/pubmed/34577592 http://dx.doi.org/10.3390/ph14090892 |
_version_ | 1784572838173212672 |
---|---|
author | Rizzuti, Bruno Ceballos-Laita, Laura Ortega-Alarcon, David Jimenez-Alesanco, Ana Vega, Sonia Grande, Fedora Conforti, Filomena Abian, Olga Velazquez-Campoy, Adrian |
author_facet | Rizzuti, Bruno Ceballos-Laita, Laura Ortega-Alarcon, David Jimenez-Alesanco, Ana Vega, Sonia Grande, Fedora Conforti, Filomena Abian, Olga Velazquez-Campoy, Adrian |
author_sort | Rizzuti, Bruno |
collection | PubMed |
description | Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (K(i) = 0.81 μM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (K(i) = 4.1 μM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds. |
format | Online Article Text |
id | pubmed-8465303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84653032021-09-27 Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds Rizzuti, Bruno Ceballos-Laita, Laura Ortega-Alarcon, David Jimenez-Alesanco, Ana Vega, Sonia Grande, Fedora Conforti, Filomena Abian, Olga Velazquez-Campoy, Adrian Pharmaceuticals (Basel) Article Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (K(i) = 0.81 μM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (K(i) = 4.1 μM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds. MDPI 2021-09-01 /pmc/articles/PMC8465303/ /pubmed/34577592 http://dx.doi.org/10.3390/ph14090892 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rizzuti, Bruno Ceballos-Laita, Laura Ortega-Alarcon, David Jimenez-Alesanco, Ana Vega, Sonia Grande, Fedora Conforti, Filomena Abian, Olga Velazquez-Campoy, Adrian Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds |
title | Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds |
title_full | Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds |
title_fullStr | Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds |
title_full_unstemmed | Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds |
title_short | Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds |
title_sort | sub-micromolar inhibition of sars-cov-2 3clpro by natural compounds |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465303/ https://www.ncbi.nlm.nih.gov/pubmed/34577592 http://dx.doi.org/10.3390/ph14090892 |
work_keys_str_mv | AT rizzutibruno submicromolarinhibitionofsarscov23clprobynaturalcompounds AT ceballoslaitalaura submicromolarinhibitionofsarscov23clprobynaturalcompounds AT ortegaalarcondavid submicromolarinhibitionofsarscov23clprobynaturalcompounds AT jimenezalesancoana submicromolarinhibitionofsarscov23clprobynaturalcompounds AT vegasonia submicromolarinhibitionofsarscov23clprobynaturalcompounds AT grandefedora submicromolarinhibitionofsarscov23clprobynaturalcompounds AT confortifilomena submicromolarinhibitionofsarscov23clprobynaturalcompounds AT abianolga submicromolarinhibitionofsarscov23clprobynaturalcompounds AT velazquezcampoyadrian submicromolarinhibitionofsarscov23clprobynaturalcompounds |